Details for New Drug Application (NDA): 203168
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in PROLENSA is bromfenac sodium. Seven suppliers are listed for this compound. Additional details are available on the bromfenac sodium profile page.
Summary for 203168
Tradename: | PROLENSA |
Applicant: | Bausch And Lomb |
Ingredient: | bromfenac sodium |
Patents: | 9 |
Pharmacology for NDA: 203168
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 203168
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PROLENSA | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 203168 | NDA | Bausch & Lomb Incorporated | 24208-602 | 24208-602-03 | 1 BOTTLE, DROPPER in 1 CARTON (24208-602-03) / 3 mL in 1 BOTTLE, DROPPER |
PROLENSA | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 203168 | NDA | Bausch & Lomb Incorporated | 24208-602 | 24208-602-04 | 1 BOTTLE, DROPPER in 1 CARTON (24208-602-04) / 3 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.07% ACID | ||||
Approval Date: | Apr 5, 2013 | TE: | RLD: | Yes | |||||
Patent: | See Plans and Pricing | Patent Expiration: | Nov 19, 2032 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | See Plans and Pricing | Patent Expiration: | Sep 11, 2025 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patent: | See Plans and Pricing | Patent Expiration: | Jan 16, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription